Alterations in the cellular immune response of patients with cerebral glioma, benign intracranial tumour, and spontaneous subarachnoid haemorrhage measured in vitro by the leucocyte migration inhibition test.
Leucocyte migration inhibition in response to ubiquitous antigens was studied in 104 patients as an in vitro indicator of cell-mediated immunity. Patients with cerebral glioma, benign intracranial tumours, and subarachnoid haemorrhage demonstrated impaired inhibition of leucocyte migration compared with control subjects. The greatest impairment occurred in patients with subarachnoid haemorrhage, while the least impairment was seen in patients with glioma. Significant rises in inhibition of leucocyte migration in response to antigen preparations from glioma and normal brain were seen in the early post-operative period in patients with glioma and subarachnoid haemorrhage. Impaired cellular immunity, together with sensitivity of lymphocytes to brain-derived antigens, are features of cerebral disease in general and not specific for glioma.
D000236:Adenoma / Q000276:immunology; D001932:Brain Neoplasms / Q000276:immunology*; D002464:Cell Migration Inhibition; D003397:Craniopharyngioma / Q000276:immunology; D005910:Glioma / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D007962:Leukocytes / Q000276:immunology*; D008579:Meningioma / Q000276:immunology; D009464:Neuroma, Acoustic / Q000276:immunology; D010911:Pituitary Neoplasms / Q000276:immunology*; D013345:Subarachnoid Hemorrhage / Q000276:immunology*